These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2893234)

  • 1. Inhibition of cardiac Na+, K+-ATPase activity by dynorphin-A and ethylketocyclazocine.
    Maeda S; Nakamae J; Inoki R
    Life Sci; 1988; 42(4):461-8. PubMed ID: 2893234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive inotropic action of kappa opiate agonists, ethylketocyclazocine and dynorphin-A(1-13), in isolated rat atrium.
    Maeda S; Nakamae J; Inoki R
    Jpn J Pharmacol; 1987 Sep; 45(1):125-8. PubMed ID: 2890782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Ca++-ATPase of rat erythrocyte membranes by k-opioid agonists.
    Yamasaki Y; Way EL
    Neuropeptides; 1985 Feb; 5(4-6):359-62. PubMed ID: 2860593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN; Hogenboom F; Mulder AH
    Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin-(1-13) restores the potency of morphine on the tolerant guinea pig ileum.
    Rezvani A; Way EL
    Eur J Pharmacol; 1984 Jul; 102(3-4):475-9. PubMed ID: 6149134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of selective and non-selective kappa-opioid receptor agonists on cutaneous C-fibre-evoked responses of rat dorsal horn neurones.
    Knox RJ; Dickenson AH
    Brain Res; 1987 Jul; 415(1):21-9. PubMed ID: 2887243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite central cardiovascular effects of various morphine-like drugs and opiate peptides in the rat.
    Laurent S; Schmitt H
    Eur Heart J; 1983 Nov; 4 Suppl G():61-5. PubMed ID: 6363080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological effects of dynorphin peptides on hippocampal pyramidal cells in rat.
    Moises HC; Walker JM
    Eur J Pharmacol; 1985 Jan; 108(1):85-98. PubMed ID: 2858395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum.
    Yoshimura K; Huidobro-Toro JP; Way EL
    Eur J Pharmacol; 1982 Oct; 84(1-2):17-24. PubMed ID: 6128236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analgesia induced by intrathecal injection of dynorphin B in the rat.
    Han JS; Xie GX; Goldstein A
    Life Sci; 1984 Apr; 34(16):1573-9. PubMed ID: 6371415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of opioid receptors modulating noradrenaline release in the hippocampus of the rabbit.
    Jackisch R; Geppert M; Illes P
    J Neurochem; 1986 Jun; 46(6):1802-10. PubMed ID: 2871130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa-receptor mechanisms in synaptosomal Ca uptake.
    Toru T; Konno F; Takayanagi I; Hirobe M
    Gen Pharmacol; 1989; 20(2):249-52. PubMed ID: 2565850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
    Shearman GT; Schulz R; Schiller PW; Herz A
    Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin A: inhibitory effect on other opiate ligand bindings in the mouse brain.
    Garzón J; Sánchez-Blázquez P; Gerhart J; Loh HH; Lee NM
    Biochem Pharmacol; 1984 Aug; 33(16):2609-14. PubMed ID: 6147144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL; Shea-Donohue T
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of opioid receptors in the cat carotid body involved in chemosensory depression in vivo.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1986 Aug; 88(4):889-98. PubMed ID: 2874862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prostaglandin A2 on Na+-K+-ATPase in basolateral plasma membrane of rat intestine in vitro inhibition of activation of K+-dependent p-nitrophenylphosphatase by Na+ and ATP.
    Matsukawa R; Terao N; Hayakawa M; Takiguchi H
    Int J Biochem; 1983; 15(5):739-41. PubMed ID: 6305739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.